Division of Clinical Pharmacology and Toxicology, Geneva University Hospitals, Geneva, Switzerland.
1] Division of Clinical Pharmacology and Toxicology, Geneva University Hospitals, Geneva, Switzerland [2] Swiss Center for Applied Human Toxicology, Geneva, Switzerland.
Clin Pharmacol Ther. 2014 Sep;96(3):349-59. doi: 10.1038/clpt.2014.83. Epub 2014 Apr 10.
The suitability of the capillary dried blood spot (DBS) sampling method was assessed for simultaneous phenotyping of cytochrome P450 (CYP) enzymes and P-glycoprotein (P-gp) using a cocktail approach. Ten volunteers received an oral cocktail capsule containing low doses of the probes bupropion (CYP2B6), flurbiprofen (CYP2C9), omeprazole (CYP2C19), dextromethorphan (CYP2D6), midazolam (CYP3A), and fexofenadine (P-gp) with coffee/Coke (CYP1A2) on four occasions. They received the cocktail alone (session 1), and with the CYP inhibitors fluvoxamine and voriconazole (session 2) and quinidine (session 3). In session 4, subjects received the cocktail after a 7-day pretreatment with the inducer rifampicin. The concentrations of probes/metabolites were determined in DBS and plasma using a single liquid chromatography-tandem mass spectrometry method. The pharmacokinetic profiles of the drugs were comparable in DBS and plasma. Important modulation of CYP and P-gp activities was observed in the presence of inhibitors and the inducer. Minimally invasive one- and three-point (at 2, 3, and 6 h) DBS-sampling methods were found to reliably reflect CYP and P-gp activities at each session.
采用鸡尾酒法评估了毛细管干血斑(DBS)采样法同时检测细胞色素 P450(CYP)酶和 P-糖蛋白(P-gp)表型的适用性。10 名志愿者分别接受了含低剂量探针的口服鸡尾酒胶囊,这些探针包括安非他酮(CYP2B6)、氟比洛芬(CYP2C9)、奥美拉唑(CYP2C19)、右美沙芬(CYP2D6)、咪达唑仑(CYP3A)和非索非那定(P-gp),以及咖啡/可乐(CYP1A2),共 4 次。他们分别在 1 次(第 1 次)、2 次(第 2 次)和 3 次(第 3 次)时接受了鸡尾酒法,并且在第 2 次和第 3 次时还接受了 CYP 抑制剂氟伏沙明和伏立康唑以及奎尼丁的处理。第 4 次时,志愿者在接受了诱导剂利福平预处理 7 天后接受了鸡尾酒法。采用单一液相色谱-串联质谱法测定 DBS 和血浆中探针/代谢物的浓度。DBS 和血浆中的药物药代动力学特征相似。在抑制剂和诱导剂存在的情况下,观察到 CYP 和 P-gp 活性的重要调节。发现单一点和三点(2、3 和 6 h)DBS 采样方法能够可靠地反映每次研究中的 CYP 和 P-gp 活性。